Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series.

Altwegg, Romain

Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series. [electronic resource] - Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 07 2018 - 668-674 p. digital

Publication Type: Journal Article; Multicenter Study

1878-3562

10.1016/j.dld.2018.02.014 doi


Adalimumab--therapeutic use
Adolescent
Adrenal Cortex Hormones--therapeutic use
Adult
Cholangitis, Sclerosing--complications
Colonoscopy
Colorectal Neoplasms
Disease Progression
Drug Therapy, Combination
Female
France
Humans
Immunosuppressive Agents--therapeutic use
Inflammatory Bowel Diseases--drug therapy
Infliximab--therapeutic use
Liver Transplantation--adverse effects
Male
Middle Aged
Remission Induction
Retrospective Studies
Tacrolimus--therapeutic use
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Young Adult